The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...

It's not easy to tell these health conditions apart based on their symptoms alone. Find out about the differences between these illnesses.

A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking ...

A contingent of vaccine skeptics in the New Hampshire House of Representatives has again brought a slate of vaccine-related ...

Moderna’s mRNA-1010 was expected to contribute $1 billion to the company’s coffers by 2028. That plan is now out the window after the FDA refused to even look at the application.

RFK Jr.'s attacks on vaccines go beyond changing the childhood immunization schedule. Now he's taking aim at vaccine R&D itself.

Moderna said it’s requesting a meeting with the U.S. Food and Drug Administration after receiving a “refusal-to-file” letter, which means the FDA isn’t going to review the company’s advanced-stage ...

HHS Spokesman Andrew Nixon told The National News Desk via email that the FDA rejected Moderna’s application for filing ...

LAS VEGAS (KVVU/Gray News) — An investigation involving the Federal Bureau of Investigation has unveiled what officials are calling a “biological lab” in Las Vegas early Saturday morning. According to ...

Leading vaccine researchers say that the proposed vaccine trials could lead to unreliable conclusions on already-approved vaccines.

Correction: This story was updated to clarify a statement given by Department of Health and Human Services spokesperson Andrew Nixon. Moderna said on Tuesday that the Food and Drug Administration (FDA ...